Skip to main content
  • JIVE (LARIMAR)

    To evaluate the safety and tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of subcutaneous (SC) administration of CTI-1601 over 28 days in subjects with Friedreich's ataxia (FRDA).

    Investigator
    Sub Subramony
    Ages
    18 Years - N/A
    Sexes
    All
  • Frataxin

    The purpose of this research study is to determine a way to measure frataxin messenger RNA (mRNA) in fluids such as blood and cerebrospinal fluid (CSF) from patients with Friedreich's ataxia (FRDA). The gene mutation in FRDA leads to low levels of…

    Investigator
    Sub Subramony
    Ages
    18 Years - 65 Years
    Sexes
    All
  • TRACK-FA

    This is a natural history study prospectively investigating neuroimaging markers of disease progression in children and adults with Friedreich ataxia (FA). There will be three assessment periods (baseline, 12 and 24 months). The study will include…

    Ages
    5 Years - N/A
    Sexes
    All